Skip Navigation

NIH: National Institutes of Health
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español Drugs of Abuse & Related Topics
NIDA Home > About NIDA > Organization > Intramural Research Program > Behavioral Neuroscience Research Branch

Intramural Research Program (IRP)

Behavioral Neuroscience Research Branch

Intracranial Injections Unit

Overview

Our research goal is to understand neurobiological bases of motivation and emotion. We have been focusing on neurochemical and anatomical mechanisms involved in the rewarding effects of drugs and other rewards such as food, using the rat model. We believe that our findings help understand motivational disorders such as drug addiction, manic, depression, and excessive eating, and may shed some lights on treatments of these disorders.



Areas of Research and Future Directions

Behavioral Neuroscience, Neuropsychopharmacology, Motivation, Emotion, Learning

We try to determine what psychological functions the mesolimbic dopamine system mediates and how it mediates in relation to the rest of basal ganglia structures, using anatomical, pharmacological (microinjections, voltammetry and microdialysis) and lesion tools. In addition, we are findings that non-basal ganglia structures including the midbrain raphe nuclei, posterior hypothalamic area, and septal region mediate similar psychological functions as the medial component of the mesolimbic dopamine system. We would like to determine if these non-dopaminergic systems interact with the dopaminergic system for psychological functions including reward, arousal and learning, and, if so, how they do.



Branch Chief and PI Names

Roy A. Wise
Chief, Behavioral Neuroscience Research Branch

Satoshi Ikemoto
Tenure-track Investigator



Members in the Unit

Satoshi Ikemoto, PhD - Chief
Junran Cao, PhD
Lynnsay Marsan
Rick Shin, PhD



Recent Selected Publications

Liu ZH, Shin R, Ikemoto S (2008). Dual role of medial A10 dopamine neurons in affective encoding. Neuropsychopharmacology, in press.

Ikemoto S (2007). Dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Research Reviews, 56: 27-78. (Review)

Liu ZH, Ikemoto S (2007). The midbrain raphe nuclei mediate primary reinforcement via GABAA receptors. European Journal of Neuroscience, 25:735-743.

Zangen A, Solinas M, Ikemoto S, Goldberg SR, Wise RA (2006). Two brain sites for cannabinoid reward. The Journal of Neuroscience, 26: 4901-4907.

Ikemoto S, Qin M, Liu ZH. (2006). Primary reinforcing effects of nicotine are triggered from multiple regions both inside and outside the ventral tegmental area. The Journal of Neuroscience, 26: 723-730.

Ikemoto S, Qin M, Liu ZH (2005). The functional divide for primary reinforcement of d-amphetamine lies between the medial and lateral ventral striatum: Is the division of the accumbens core, shell and olfactory tubercle valid? The Journal of Neuroscience, 25:5061-5065.

Ikemoto S (2005). The supramammillary nucleus mediates primary reinforcement via GABAA receptors. Neuropsychopharmacology, 30:1088-1095.

Ikemoto S, Wise RA (2004). Mapping of chemical trigger zones for reward. Neuropharmacology, 47: 190-201. (Review)

Ikemoto S, Witkin BM, Zangen A, Wise RA (2004). Rewarding effects of AMPA administration into the supramammillary or posterior hypothalamic nuclei but not the ventral tegmental area. The Journal of Neuroscience, 24: 5758-5765.

Ikemoto S (2003). Involvement of the olfactory tubercle in cocaine reward: intracranial self-administration studies. The Journal of Neuroscience, 23: 9305-9311.

Ikemoto S, Wise RA (2002). Rewarding effects of the cholinergic agents carbachol and neostigmine in the posterior ventral tegmental area. The Journal of Neuroscience, 22:9895-9904.

Ikemoto S (2002). Ventral striatal anatomy of locomotor activity induced by cocaine, d-amphetamine, dopamine and D1/D2 agonists. Neuroscience, 113:939-955.

Zangen A, Ikemoto S, Zadina JE, Wise RA (2002). Rewarding and psychomotor stimulant effects of endomorphin-1: anteroposterior differences within the ventral tegmental area and lack of effect in nucleus accumbens. The Journal of Neuroscience, 22:7225-7233.

Burgdorf J, Knutson B, Panksepp J, Ikemoto S (2001). Nucleus accumbens amphetamine microinjections unconditionally elicit 50 kHz ultrasonic vocalization in rats. Behavioral Neuroscience, 115:940-944.

Ikemoto S, Sharpe LG (2001). A head-attachable device for injecting nanoliter volumes of drug solutions into brain sites of freely moving rats. Journal of Neuroscience Methods, 110:135-140.

Ikemoto S, Panksepp J (1999). The role of nucleus accumbens dopamine in motivated behavior: A unifying interpretation with special reference to reward seeking. Brain Research Reviews, 31:6-41. (Review)

Behavioral Neuroscience Research Branch



NIDA Home | Site Map | Search | FAQs | Accessibility | Help | Privacy | FOIA (NIH) | Employment | Print Version


National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Monday, February 25, 2008. The U.S. government's official web portal